Featured
-
-
Article
| Open Access
Immunomodulatory drugs have divergent effects on humoral and cellular immune responses to SARS-CoV-2 vaccination in people living with rheumatoid arthritis
- Jenna M. Benoit
- , Jessica A. Breznik
- & Dawn M. E. Bowdish
-
Article
| Open Access
Impact of sex and age on vaccine-related side effects and their progression after booster mRNA COVID-19 vaccine
- Masahiko Mori
- , Aiko Yokoyama
- & Tadayoshi Moriyama
-
Article
| Open Access
Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2
- Brian C. Gau
- , Andrew W. Dawdy
- & Jason C. Rouse
-
Article
| Open Access
Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults
- Simon Dedroogh
- , Sven Schmiedl
- & Michael Dedroogh
-
Article
| Open Access
Epigenomic landscape exhibits interferon signaling suppression in the patient of myocarditis after BNT162b2 vaccination
- Hyeonhui Kim
- , Hyo-Suk Ahn
- & Sungsoon Fang
-
Article
| Open Access
Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
- Natalia Martin-Orozco
- , Noah Vale
- & Piyush Patel
-
Article
| Open Access
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
- Pekka Kolehmainen
- , Moona Huttunen
- & Ilkka Julkunen
-
Article
| Open Access
Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta)
- Dan Qi Priscilla Oh
- , Iris Grothe
- & Detlef Wegener
-
Article
| Open Access
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients
- Enzo Maria Ruggeri
- , Fabrizio Nelli
- & Maria Assunta Silvestri
-
Article
| Open Access
Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients
- Avishai Maliah
- , Roma Parikh
- & Shaye Kivity
-
Article
| Open Access
Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
- Jie Bai
- , Asako Chiba
- & Sachiko Miyake
-
Article
| Open Access
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
- Henning Jacobsen
- , Monika Strengert
- & Luka Cicin-Sain
-
Article
| Open Access
Immediate protein expression from exogenous mRNAs in embryonic brain
- Masae Naruse
- & Tetsuichiro Saito
-
Article
| Open Access
Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
- Cheng Siang Tan
- , Vaenessa Noni
- & Sian Kong Tan
-
Article
| Open Access
Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells
- Jun Shimizu
- , Tadahiro Sasaki
- & Tatsuo Shioda
-
Article
| Open Access
Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans
- Mariem Gdoura
- , Fatma Ben Ghaloum
- & Chokri Bahloul
-
Article
| Open Access
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine
- Chiara Agrati
- , Concetta Castilletti
- & Eliana Specchiarello
-
Article
| Open Access
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies
- Maryam Khan
- , Carolina Rosadas
- & Richard S. Tedder
-
Article
| Open Access
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection
- F. Gianfagna
- , G. Veronesi
- & M. M. Ferrario
-
Article
| Open Access
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
- Kenji Maeda
- , Masayuki Amano
- & Hiroaki Mitsuya
-
Article
| Open Access
The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta
- Reza Keikha
- , Seyed Mohammad Hashemi-Shahri
- & Ali Jebali
-
Article
| Open Access
Infectious RNA vaccine protects mice against chikungunya virus infection
- Inga Szurgot
- , Karl Ljungberg
- & Peter Liljeström
-
Article
| Open Access
Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas
- Susan K. Rathe
- , Flavia E. Popescu
- & David A. Largaespada
-
Article
| Open Access
Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken
- Yun Zhang
- , Ying Wei
- & Yongchang Cao
-
Article
| Open Access
Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs
- Meret E. Ricklin
- , Sylvie Python
- & Artur Summerfield
-
Article
| Open Access
Antibody production by in vivo RNA transfection
- Bizhan Romani
- , Amirarsalan Kavyanifard
- & Elham Allahbakhshi
-
Article
| Open Access
An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model
- Jasdave S. Chahal
- , Tao Fang
- & Hidde L. Ploegh
-
Article
| Open Access
Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
- Lukasz Bialkowski
- , Alexia van Weijnen
- & Kris Thielemans
-
Article
| Open Access
Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity
- Kyle K. L. Phua
- , Herman F. Staats
- & Smita K. Nair
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series